- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Doctor Anywhere gets administered series C funding
Novo and Philips Venture have joined existing investor IHH Healthcare in a $65.7m series C round for healthcare booking platform developer Doctor Anywhere.
Aug 31, 2021Olive launches venture studio
The Alphabet-backed healthcare management software developer has formed a venture studio for startups from the healthcare industry.
Aug 31, 2021Analysis: Large corporate-backed rounds
Last year we saw a record number of corporate-backed rounds sized $100 and above and this year has not been any different, already setting records.
Aug 30, 2021Daily Deal Round Up: August 27, 2021
Opt's Bonds Investment Group led interior design sharing platform RoomClip's series E round in addition to online learning platform developer Schoo's series D.
Aug 27, 2021Daily deal net: August 27, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 27, 2021Genuine Biotech gets real with $100m
Shanghai Desano Pharmaceuticals has contributed to a series B round for the antiviral, cancer and cardiovascular drug developer, which is seeking to list in Hong Kong.
Aug 27, 2021Lynk Pharmaceuticals connects to $50m
Lilly Asia Ventures led the Sinopharm-backed oncology, immunity and inflammation therapeutics startup’s series B round, which included Legend Capital.
Aug 27, 2021AllStripes collects $50m in series B round
McKesson Ventures and Medidata Solutions participated in a round that will help the medical data provider in the fight against rare diseases.
Aug 27, 2021FlexDex figures out $13m series AA
University of Michigan has further supported its spinout FlexDex Surgical with an investment in a series AA round through Mints and Michigan Biomedical Venture Fund.
Aug 27, 2021Yeasen seizes series B-plus funding
Legend Capital took part in a $46.3m series B-plus round for enzyme product developer Yeasen Biotechnology two months after the latter closed its series B round.
Aug 27, 2021Nuvectis negotiates $15m series A
Based on research at Institute for Cancer Research, Nuvectis Pharma is working on precision medicines for cancer.
Aug 27, 2021Daily Deal Round Up: August 26, 2021
Ferrovial and Mitsui Fudosan helped mobility platform developer Maas Global hike its latest round to nearly $46m while automotive technology developer Visic Technologies raised $35m.
Aug 26, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


